GEM

Gujarat Health & Family Welfare Department Insulin Injection Testing Labs Tender 2025 – 10 ml vial, OEM authorization

Bid Publish Date

27-Oct-2025, 12:43 pm

Bid End Date

06-Nov-2025, 1:00 pm

Bid Opening Date

06-Nov-2025, 1:30 pm

Progress

Issue27-Oct-2025, 12:43 pm
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

6000

Bid Type

Two Packet Bid

Key Highlights

  • OEM AUTHORIZATION CERTIFICATE MENTIONING THE BID NUMBER MANDATORY
  • Contract quantity or duration may vary up to 25% at issue and post-issuance
  • Category involves testing laboratories for insulin injection (10 ml vial)
  • ATC terms imply flexible price offers aligned with input technical specs
  • No BOQ items or estimated value disclosed; verify scope with agency

Tender Overview

The Gujarat Health & Family Welfare Department seeks selection of laboratories for testing insulin injection products, focusing on 10 ml vial presentations. The tender emphasizes service-provider access to input product-specific technical specifications to enable price offers, with emphasis on insulin injection testing. A key differentiator is the need for an OEM authorization certificate tied to the bid number, ensuring supplier credibility. The scope appears to revolve around testing services for injectable insulin and related materials, with a flexible quantity/duration framework under a 25% variation clause. Location and final contract specifics are not disclosed in the data provided.

Technical Specifications & Requirements

No explicit technical specifications are published. Based on the category, potential requirements may include:

  • Product/service: Laboratory testing for insulin injection materials (10 ml vial)
  • Standards/compliance: OEM authorization certificate mandatory; quantities may vary by up to 25% at contract issuance; ATC terms allow quantity/duration adjustments
  • Deliverables: Price offers aligned to inputted technical specs; testing reports for insulin injection batches
  • Qualifications: Laboratory capability to test pharmaceutical injectable products; ability to interpret insulin vial specifications
  • Documentation: OEM authorization referenced to the bid number; bidder must demonstrate testing capability for injectable pharmaceuticals
  • BOQ: No items listed; no explicit quantity or value available

Terms, Conditions & Eligibility

Key terms include a 25% variation clause on quantity or contract duration at issue and post-issuance; OEM AUTHORIZATION CERTIFICATE mentioning the bid number is mandatory; bidders failing this will be rejected. The terms indicate a generic ATC with no further schedule or payment details provided. No BOQ items or estimated value are disclosed, necessitating bidders to confirm technical feasibility and compliance through OEM-backed testing capability for insulin injections.

Key Specifications

  • Product/service: Laboratory testing of insulin injection products (10 ml vial)

  • Quantities/duration: Variation up to 25% at contract issuance

  • Standards/certifications: OEM authorization certificate required

  • Deliverables: Testing reports aligned to inputted technical specs

Terms & Conditions

  • Mandatory OEM authorization mentioning bid number

  • Quantity/duration variation limit: 25%

  • No BOQ/estimated value provided; confirm scope with buyer

Important Clauses

OEM Authorization Certification

Bidders must provide OEM authorization certificate explicitly referencing the bid number; absence leads to rejection.

Quantity Variation

Contract quantity or duration may be adjusted by up to 25% at the time of contract issuance and thereafter.

Bidder Eligibility

  • Laboratory with pharmaceutical testing capability for injectable products

  • Compliance with OEM-based authorization and related regulatory standards

  • Financial stability evidence and GST registration

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

OEM authorization certificate mentioning the bid number

2

Laboratory accreditation/cacert for pharmaceutical testing (if applicable)

3

GST registration and PAN card

4

Experience certificates in pharmaceutical testing

5

Financial staments or turnover proof (if requested later)

6

Technical bid documents demonstrating testing capability for insulin injections

7

Any prior testing reports for insulin 10 ml vial products

Frequently Asked Questions

How to participate in insulin testing tender in Gujarat 2025

Bidders must submit OEM authorization referencing the bid number, GST registration, PAN, and laboratory credentials proving injectable pharma testing capability. Include technical bid documents and experience certificates in pharmaceutical testing to demonstrate compliance with required standards and the ability to handle 10 ml vial insulin products.

What documents are required for insulin testing bid in Gujarat

Submit OEM authorization certificate with bid number, GST certificate, PAN, lab accreditation, and experience certificates in injectable pharmaceutical testing. Provide financial statements if requested, along with technical bid detailing testing methodology for insulin injections (10 ml vial) and prior related reports.

What are the key requirements for insulin vial testing labs in Gujarat

Essential requirements include an OEM authorization mentioning the bid number, demonstrable testing capability for insulin injections, and financial/registration documentation. The contract allows up to 25% variation in quantity or duration, so bid should accommodate scalable testing capacity for 10 ml vials.

How is quantity variation applied in insulin testing tender

Quantity or contract duration can be increased up to 25% at contract issue and after award. Bidders should plan capacity to scale testing of insulin injection batches by at least one quarter and align pricing accordingly.

When will acceptance criteria for insulin testing labs be defined

Acceptance criteria are defined by OEM authorization and demonstrated testing capability for 10 ml insulin vials. Ensure documentation shows alignment with the bid number and that testing methodology can produce compliant insulin injection test results.

What standards/expertise are required for insulin testing labs in Gujarat

Mandatory OEM authorization is required; laboratories must prove injectable pharmaceutical testing experience and compliance with relevant regulatory standards. While specific standards are not listed, alignment with pharmaceutical testing norms and traceability of test results is essential.

What if OEM authorization is not available for insulin testing bid

Bidder will likely be rejected as OEM authorization mentioning the bid number is mandatory. Seek immediate OEM engagement or partner with an authorized testing lab to obtain the required certificate before submission.

Similar Tenders

Selection of Laboratories for Testing of Products/Material - Soil; Buyer to use custom filter to in

Department of Military Affairs

RAJAURI, JAMMU & KASHMIR

Est: ₹61,400
View Details